Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Healthcare Diagnostics & Research Medical Instruments & Supplies

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, Russia, and internationally. The company markets Endotoxin Activity Assay, a rapid in-vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B-Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops, manufactures, and markets monoclonal and polyclonal antibodies, recombinant cardiac proteins, antibodies, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

TSX:EDT - Post by User

Spectral Medical Inc

<< Previous

Bullboard Posts

Next >>

(352)
•••

Comment by hmmmmmmmmon Sep 10, 2025 11:09am

124 Views

Post# 36709380

RE:SEPSIS EMERGENCY

A WHO call to action for national plans for early diagnosis and treatment of sepsis, ESS... which it calls "a leading cause of death worldwide".

With such desperate need, and no precision options- just imagine the acceptance and market penetration of EAA, PMX and Targeted Rapid Endotoxin Adsorption (TREA) Therapy.

<< Previous

Bullboard Posts

Next >>

Micron is getting out of the consumer business when it is needed the most